Neuroscience
Parkinson's Disease
100%
Leucine Rich Repeat Kinase 2
74%
Neurodegeneration
34%
Kinase
33%
Phospholipase D2
22%
Phospholipase D1
18%
Protein Kinase C
18%
Dopaminergic
16%
Phospholipase D
15%
Caveolin
14%
Synuclein
13%
Parkin
11%
In Vivo
11%
Protein Binding
10%
Cell Membrane
9%
Microtubule
9%
Guanosine Triphosphate
9%
In Vitro
9%
Epidermal Growth Factor
9%
Glucocorticoid Receptor
9%
Brain Injury
9%
Ciliary Neurotrophic Factor
9%
Growth Cone
9%
Dynamin
9%
Ribosome Protein
9%
Transcription Initiation
9%
Glycogen Synthase Kinase 3
9%
Neurite Outgrowth
9%
Vanilloid Receptor 1
9%
Hypoxia Inducible Factor 1
9%
Tonicity
9%
Enhancer Region
9%
Astrocyte
9%
Microglia
9%
Caenorhabditis Elegans
9%
Transactivation
9%
Palmitoylation
9%
Rab Protein
8%
Neuroprotective Agent
6%
Phorbol
5%
Myristic Acid
5%
Bradykinin
5%
Cell Line
5%
Neurotrauma
5%
Traumatic Brain Injury
5%
Dopaminergic Neuron
5%
Epidermal Growth Factor Receptor
5%
Biochemistry, Genetics and Molecular Biology
Phosphotransferase
54%
Kinase
54%
Leucine-Rich Repeat
53%
Phospholipase
32%
Protein Kinase C
25%
PLD2
25%
Phospholipase D
21%
Epidermal Growth Factor
19%
Phospholipase D1
18%
Caveolin
15%
Bradykinin
14%
Epidermal Growth Factor Receptor
14%
Glucose Blood Level
13%
LRRK2
13%
Dopaminergic
12%
Cell Membrane
11%
Growth Cone
10%
Ribosomal Protein
9%
Insulin Release
9%
Mutant Protein
9%
Dynamin
9%
Guanosine Triphosphate
9%
Neurite Outgrowth
9%
Adenosine Diphosphate Ribose
9%
Hydrogen Peroxide
9%
Glycogen Synthase Kinase 3
9%
Palmitoylation
9%
DNA Damage
8%
Cetuximab
7%
Synuclein
6%
Parthanatos
6%
Lecithinase
5%
Cell Death
5%
Ubiquitin-Conjugating Enzyme
5%
Autosomal Dominant Inheritance
5%
Transcription
5%
Lysophosphatidylcholine
5%
Caveolae
5%
Leukocyte
5%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
60%
Leucine Rich Repeat Kinase 2
42%
Epidermal Growth Factor Receptor
18%
Phosphotransferase
17%
Synuclein
14%
Protein Kinase C
13%
Phospholipase D1
13%
Caveolin
11%
Receptor
10%
Phospholipase D2
9%
Head and Neck Cancer
9%
HIV
9%
Nonnucleoside Reverse Transcriptase Inhibitor
9%
Prevalence
9%
Poly(adenosine Diphosphate Ribose)
9%
Insulin Resistance
9%
Dopamine Receptor Stimulating Agent
8%
Phospholipase D
8%
Cetuximab
7%
Ubiquitin Protein Ligase E3
5%
Lecithinase
5%
Epidermal Growth Factor
5%
Injury
5%
Pheochromocytoma
5%